SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-042411
Filing Date
2021-03-26
Accepted
2021-03-26 16:01:16
Documents
20
Period of Report
2021-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2110788d1_8k.htm   iXBRL 8-K 33205
2 EXHIBIT 1.1 tm2110788d1_ex1-1.htm EX-1.1 262190
3 EXHIBIT 5.1 tm2110788d1_ex5-1.htm EX-5.1 9543
4 EXHIBIT 99.1 tm2110788d1_ex99-1.htm EX-99.1 13474
5 EXHIBIT 99.2 tm2110788d1_ex99-2.htm EX-99.2 14353
9 GRAPHIC tm2110788d1_ex5-1img001.jpg GRAPHIC 8374
10 GRAPHIC tm2110788d1_ex5-1img002.jpg GRAPHIC 2833
11 GRAPHIC tm2110788d1_ex99-1img01.jpg GRAPHIC 4215
12 GRAPHIC tm2110788d1_ex99-2img01.jpg GRAPHIC 4215
  Complete submission text file 0001104659-21-042411.txt   614513

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA casi-20210323.xsd EX-101.SCH 3187
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20210323_lab.xml EX-101.LAB 34592
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20210323_pre.xml EX-101.PRE 22711
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2110788d1_8k_htm.xml XML 3619
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 21777229
SIC: 2836 Biological Products, (No Diagnostic Substances)